OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
16 hedge funds and large institutions have $1.89M invested in OncoSec Medical Incorporated in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 6 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
92% more capital invested
Capital invested by funds: $987K → $1.89M (+$906K)
20% less funds holding
Funds holding: 20 → 16 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$227K |
| 2 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$98.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$47K |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$40.3K |
| 5 |
BlackRock
New York
|
+$40K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
-$54K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$37K |
| 3 |
LPL Financial
San Diego,
California
|
-$31K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$10K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.87K |
ONCS Hedge Fund Activity: Q2 2020 in Review
16 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2020, worth a combined $1.89M — up 92% from $987K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ONCS and 2 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, adding an estimated $227K. The largest seller was CSS LLC, exiting entirely with an estimated $54K sold.
- 16 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2020, down from 20 in Q1 2020.
- Funds reported $1.89M of OncoSec Medical Incorporated stock for Q2 2020, up 92% quarter-over-quarter.
- 2 funds opened new OncoSec Medical Incorporated positions in Q2 2020 and 6 closed out, a net change of -4 holders.
- The largest OncoSec Medical Incorporated buyer in Q2 2020 was Renaissance Technologies, an estimated $227K added.
- The largest OncoSec Medical Incorporated seller in Q2 2020 was CSS LLC, an estimated $54K sold.
Based on aggregated 13F filings for Q2 2020.